PHYSICIANS FORMULA SUN SHIELD EXTRA SENSITIVE SKIN, SPF 25 (2007 FORMULATION)
last updated: 12/01/07 brand: Physicians Formula by Physicians Formula Cosmetics
COMPANY POLICIES
Compact for Safe Cosmetics
|
Animal Testing Policy |
Sunscreen effectiveness* breakdown
| 3 | UVB hazard/exposure score |
| 2 | UVA hazard/exposure score |
| 0 | sunscreen instability |
*Note that the same active ingredient combination may score differently in two different products depending on the concentration of the ingredients and the mixture of inactive ingredients.
Active ingredient UV |
 | ||||||||||||||||||||||||||||||||||||
 Product total |
| ||||||||||||||||||||||||||||||||||||
| NANO TITANIUM DIOXIDE ( 6.9? %) |
| ||||||||||||||||||||||||||||||||||||
| NANO ZINC OXIDE (20-60nm) ( 6.3? %) |
| ||||||||||||||||||||||||||||||||||||
We have had to assume the percentage of the active ingredients in this product. If you own this product and it has the percentages printed on the package, you can help us fill in this missing information.
Note to manufacturers: We have assumed a typical particle size for the mineral(s) in your product based on typical industry use. We welcome specific data from manufacturers if actual particle size is different.
Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
 | Cancer |
| Developmental/reproductive toxicity |
| Violations, restrictions & warnings |
| Allergies/immunotoxicity |
| Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Note from EWG: Unlike many other kinds of personal care products, sunscreen can provide health benefits, protecting against the sun's cancer-causing UV radiation. More than one million cases of skin cancer are diagnosed in the U.S. every year. Health officials recommend wearing sunscreen as one of many important steps to minimize skin cancer risk. (more sun safety tips)
Note: This product formulation was obtained from the FDA VCRD.
Ingredients from packaging: TITANIUM DIOXIDE, PEG/PPG-18/18 DIMETHICONE, PETROLATUM, ZEOLITE, CAPRYLIC/CAPRIC TRIGLYCERIDE, GLYCERYL STEARATE, LAURETH-12, MINERAL OIL, HEAVY, POLYSILICONE-11, PPG-3 MYRISTYL ETHER, QUATERNIUM-18 HECTORITE, WATER, TOCOPHERYL ACETATE, XANTHAN GUM, DISODIUM EDTA, BHT, ETHYLENE BRASSYLATE, PHENOXYETHANOL, ISOPROPYLPARABEN, ISOBUTYLPARABEN, BUTYLPARABEN, IRON OXIDES, CYCLOPENTASILOXANE, ETHYLHEXYL PALMITATE, GLYCERIN, C12-15 ALKYL BENZOATE, SODIUM CHLORIDE, CETYL PEG/PPG-10/1 DIMETHICONE, ZINC OXIDE
user reviews & comments
NEW! No reviews or ratings yet. Log in and be the first to leave a comment!
ingredients
| score | data gap | concerns | |
| NANO TITANIUM DIOXIDE (Active Ingredient) | 2 | 87% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| NANO ZINC OXIDE (20-60nm) (Active Ingredient) | 3 | 70% | Violations, restrictions & warnings, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
| BUTYLPARABEN | 6 | 79% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| CETYL PEG/ PPG-10/ 1 DIMETHICONE | 4 | 76% | Organ system toxicity (non-reproductive), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| PEG/ PPG-18/ 18 DIMETHICONE | 4 | 75% | Organ system toxicity (non-reproductive), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| BHT | 6 | 61% | Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| TOCOPHERYL ACETATE | 4 | 81% | Allergies/immunotoxicity, Contamination concerns (HYDROQUINONE) |
| MINERAL OIL | 2 | 73% | Organ system toxicity (non-reproductive), Occupational hazards |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards |
| LAURETH-12 | 3 | 100% | Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| ISOPROPYLPARABEN | 3 | 84% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| ISOBUTYLPARABEN | 3 | 83% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| DISODIUM EDTA | 3 | 78% | Neurotoxicity, Organ system toxicity (non-reproductive), Enhanced skin absorption |
| WHITE PETROLATUM | 2 | 94% | Organ system toxicity (non-reproductive), Contamination concerns (PAHS) |
| IRON OXIDES | 2 | 85% | Persistence and bioaccumulation, Enhanced skin absorption |
| ZEOLITE | 2 | 83% | Cancer, Enhanced skin absorption |
| GLYCERIN | 2 | 74% | Organ system toxicity (non-reproductive), Occupational hazards |
| C12-15 ALKYL BENZOATE | 0 | 94% | none identified |
| CAPRYLIC/ CAPRIC TRIGLYCERIDE | 0 | 94% | none identified |
| PPG-3 MYRISTYL ETHER | 0 | 94% | none identified |
| ETHYLHEXYL PALMITATE | 1 | 92% | Irritation (skin, eyes, or lungs) |
| ETHYLENE BRASSYLATE | 1 | 88% | Irritation (skin, eyes, or lungs) |
| GLYCERYL MONOSTEARATE GLYCERYL STEARATE | 1 | 88% | none identified |
| POLYSILICONE-11 | 0 | 100% | none identified |
| QUATERNIUM-18 HECTORITE | 0 | 99% | none identified |
| XANTHAN GUM | 0 | 94% | none identified |
| SODIUM CHLORIDE | 0 | 0% | innocuous |
| WATER | 0 | 0% | innocuous |
Cancer*
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show tumor formation at high doses | MINERAL OIL | |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL | |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more in vitro tests on mammalian cells show positive mutation results | NANO ZINC OXIDE (20-60nm), NANO TITANIUM DIOXIDE | |
| One or more in vitro tests on mammalian cells show positive mutation results | TOCOPHERYL ACETATE, SODIUM CHLORIDE, GLYCERIN, DISODIUM EDTA, BUTYLPARABEN | |
| Cancer - not classifiable/not likely to be human carcinogen | ZEOLITE, BHT |
Developmental/reproductive toxicity*
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | DISODIUM EDTA, | |
| One or more animal studies show developmental effects at high doses | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show reproductive effects at high doses | BHT | |
| One or more animal studies show reproductive effects at moderate doses | GLYCERIN | |
| One or more animal studies show any effects at very low doses | BUTYLPARABEN |
Violations, restrictions & warnings*
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in cosmetics (concentration limit) | PHENOXYETHANOL | |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | CETYL PEG/ PPG-10/ 1 DIMETHICONE, PEG/ PPG-18/ 18 DIMETHICONE | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - any | NANO ZINC OXIDE (20-60nm) |
Neurotoxicity*
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE | |
| One or more animal studies show brain and nervous system effects at moderate doses | PHENOXYETHANOL | |
| One or more animal studies show brain and nervous system effects at high doses | GLYCERIN, NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show brain and nervous system effects at low doses | DISODIUM EDTA, BHT |
Endocrine disruption*
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | GLYCERIN, DISODIUM EDTA, BHT | |
| One or more studies show weak endocrine disruption | ISOPROPYLPARABEN | |
| One or more animal studies show endocrine disruption at moderate doses | ISOBUTYLPARABEN | |
| Human any disruptor - strong evidence | BUTYLPARABEN | |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE |
Allergies/immunotoxicity*
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| respiratory - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | NANO TITANIUM DIOXIDE | |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| Human skin toxicant - strong evidence | TOCOPHERYL ACETATE, ISOPROPYLPARABEN, ISOBUTYLPARABEN, BUTYLPARABEN | |
| Known human immune system toxicant | BHT |
Persistence and bioaccumulation*
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | NANO TITANIUM DIOXIDE, WHITE PETROLATUM | |
| Persistent, bioaccumulative in wildlife | NANO ZINC OXIDE (20-60nm), CYCLOPENTASILOXANE | |
| Persistent, bioaccumulative in wildlife and humans | IRON OXIDES |
Organ system toxicity (non-reproductive)*
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Classified as expected to be toxic or harmful | WHITE PETROLATUM | |
| One or more animal studies show blood effects at high doses (low dose studies may be unavailable for this ingredient) | ZEOLITE | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | CYCLOPENTASILOXANE |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | GLYCERYL MONOSTEARATE, TOCOPHERYL ACETATE, ETHYLENE BRASSYLATE | |
| Limited evidence of sense organ toxicity | PEG/ PPG-18/ 18 DIMETHICONE, ISOPROPYLPARABEN, CETYL PEG/ PPG-10/ 1 DIMETHICONE, ISOBUTYLPARABEN, BUTYLPARABEN | |
| One or more animal studies show sense organ effects at low doses | products for use around the eyes, mouth, or lips | SODIUM CHLORIDE, MINERAL OIL |
| One or more animal studies show broad systemic effects at low doses | DISODIUM EDTA, BHT | |
| One or more animal studies show sense organ effects at very low doses | products for use around the eyes, mouth, or lips | PHENOXYETHANOL |
| One or more animal studies show cardiovascular effects at very low doses | NANO TITANIUM DIOXIDE, GLYCERIN |
Ecotoxicology*
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be an environmental toxin | WHITE PETROLATUM | |
| Wildlife and environmental toxicity | NANO ZINC OXIDE (20-60nm) | |
| Wildlife and environmental toxicity | NANO TITANIUM DIOXIDE |
Irritation (skin, eyes, or lungs)*
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | SODIUM CHLORIDE, NANO ZINC OXIDE (20-60nm), MINERAL OIL, GLYCERIN, CYCLOPENTASILOXANE, BUTYLPARABEN | |
| One or more animal studies show skin irritation at low doses | ETHYLENE BRASSYLATE, BHT, | |
| One or more animal studies show significant but moderate pulmonary irritation at low doses | NANO TITANIUM DIOXIDE | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | ETHYLHEXYL PALMITATE |
| Classified as irritant | PHENOXYETHANOL |
Data gaps*
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Insufficient data to determine safety | NANO ZINC OXIDE (20-60nm) | |
| Safety assessment was based on related chemical | ISOBUTYLPARABEN, ZEOLITE, ISOPROPYLPARABEN | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | TOCOPHERYL ACETATE, QUATERNIUM-18 HECTORITE, PHENOXYETHANOL, GLYCERYL MONOSTEARATE, PEG/ PPG-18/ 18 DIMETHICONE, ETHYLHEXYL PALMITATE, BUTYLPARABEN, DISODIUM EDTA | |
| Not assessed for safety in cosmetics by industry panel | XANTHAN GUM, NANO TITANIUM DIOXIDE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | BHT | |
| Not assessed for safety in cosmetics by industry panel | WHITE PETROLATUM, PPG-3 MYRISTYL ETHER, POLYSILICONE-11, NANO ZINC OXIDE (20-60nm), MINERAL OIL, LAURETH-12, GLYCERIN, ETHYLENE BRASSYLATE, CYCLOPENTASILOXANE, CETYL PEG/ PPG-10/ 1 DIMETHICONE, CAPRYLIC/ CAPRIC TRIGLYCERIDE, C12-15 ALKYL BENZOATE |
Occupational hazards*
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to moderate doses | MINERAL OIL, GLYCERIN | |
| Allowed workplace exposures restricted to low doses | NANO ZINC OXIDE (20-60nm), BHT, | |
| Allowed workplace exposures restricted to low doses | PHENOXYETHANOL, NANO TITANIUM DIOXIDE |
Biochemical or cellular level changes*
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | BHT | |
| Interferes with gene expresion | BUTYLPARABEN | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | GLYCERIN, CYCLOPENTASILOXANE | |
| One or more animal studies show biochemical changes at very low doses where the human health implications are not yet well understood | NANO TITANIUM DIOXIDE |
Copyright © 2010 by Environmental Working Group
All rights reserved.
Favorites basket
No items in basket.
Add this product
Skin Deep User Tools BETA
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
SKIN DEEP NEEDS YOUR HELP
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
WANT TO KNOW MORE?
Stay informed with email updates on toxics in everyday products and how they can affect your health.
JOIN THE CAMPAIGN
Find out more about the Campaign for Safe Cosmetics.